Click on the Buy From Amazon.com link to know Amazon.com's best price & availability.
Binding: Paperback Dewey Decimal Number: 616.154 EAN: 9783540612308 ISBN: 3540612300 Label: Springer-Verlag Telos Manufacturer: Springer-Verlag Telos Number Of Items: 1 Number Of Pages: 130 Publication Date: 1997-01 Publisher: Springer-Verlag Telos Studio: Springer-Verlag Telos
Editorial Reviews for Febrile Neutropenia
Febrile neutropenia is a common complication in cancer patients and has been studied for more than 30 years. This is a field of cancer in which much progress in supportive care has been made, significantly reducing the morbidity and mortality from infections. Tremendous numbers of patients have already benefited from specific antineoplastic therapy and an even greater number could benefit from the prevention of infection or from the allevation of symptoms as a result of effective prophylaxis or adequate therapeutic strategies. This book evaluates the achievements in the past and identifies the major existing problems. It gives an overview of therapeutic possibilities and presents new concepts and strategies for making further progress.
More Information on Febrile Neutropenia
Febrile neutropenia - Wikipedia, the free encyclopedia Febrile neutropenia is the development of fever, often with other signs of infection, in a patient with neutropenia, an abnormally low number of neutrophil granulocytes (a type of ...
Febrile Neutropenia : BC Cancer Agency Febrile neutropenia occurs when a patient has a fever and a significant reduction in their white blood cells (neutropenia) that are needed to fight infections. Many patients when ...
Neutropenia Febrile Neutropenia: One technical term of which cancer patients should be aware is "Febrile Neutropenia," which refers to having a fever while the white blood cell count is low.
Imedex: Education is the Best Medicine® Intensive Care for Patients with Febrile Neutropenia Chair: Jean A. Klastersky, MD, PhD Co-Chair: Gilles Hilbert, MD. 13:30 State-of-the art lecture:
Neulasta® - First Cycle Protection The majority of febrile neutropenia-related events occur during the first cycle of chemotherapy Of those patients who developed febrile ...
Empiric Ther. of FEbrile Neutropenia X:\TRANSFER\GUIDANCE\ANTI-\2560DFT.WPD 7/21/98 Guidance for Industry Empiric Therapy of Febrile Neutropenia — Developing Antimicrobial Drugs for Treatment DRAFT GUIDANCE This ...
Chemotherapy-Induced Neutropenia Home Neutropenia is the major dose-limiting toxicity associated with cancer chemotherapy and febrile neutropenia is associated with considerable morbidity, mortality, and cost.
